Skip to main content
. Author manuscript; available in PMC: 2014 Oct 31.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2011 May 27;38(9):1732–1741. doi: 10.1007/s00259-011-1847-4

Fig. 6.

Fig. 6

Biodistributions of 18F-AlF-NOTA-RGD2, 18F-AlF-NOTA-RGD2 with c(RGDyK) as a blocking agent (10 mg/kg body weight), and 18F-FP-RGD2 in U87MG tumor-bearing athymic nude mice at 2 h p.i. Data are expressed as normalized accumulation of activity in %ID/g ± SD (n=4)